Several groups have shown elevated expression of LY6K mRNA in human head and neck squamous cell carcinomas and in lung, oesophageal, and breast cancers (de Nooij-van Dalen et al, 2003; Lee et al, 2006; Ishikawa et al, 2007). Here, LY6K is linked to breast cancer.